A B C D E F G H I J K L M N O P Q R S T U V W X Y Z All
Mittal, A.
- Contact Dermatitis to PPD in Henna - An Interesting Presentation
Authors
1 Dept of Dermatology, Venereology and Leprosy, R.N.T. Medical College, Udaipur, Rajasthan, IN
2 Dept of Dermatology, Venereology and Leprosy, G. R. Medical College, Gwalior, M. P., IN
Source
The Indian Practitioner, Vol 67, No 3 (2014), Pagination: 171-172Abstract
No Abstract.
- A Retrospective Study about Relapse among MDT Treated Leprosy Patient
Authors
1 Dept. of Dermatology, Venereology and Leprosy, RNT Medical College, Udaipur-313001, Rajasthan, IN
2 Dept. of Dermatology, Venereology and Leprosy, G R Medical College, Gwalior, MP, IN
Source
The Indian Practitioner, Vol 68, No 3 (2015), Pagination: 24-28Abstract
Background: New skin or nerve lesions may develop despite the fixed duration of multi drug therapy (MDT), in multibacillary (MB) and paucibacillary (PB) leprosy. The lesions could be due to reaction, relapse or reinfection. The index study was conducted to know the percentage of relapse in leprosy at a tertiary care hospital in Southern Rajasthan, India.
Material and Methods: The study was conducted on 29 (4 PB and 25 MB) cases, who had completed WHO guided fixed duration MDT regimens and were under regular surveillance for more than one year. Besides the relapse criteria laid by Beck-Bleumink, we performed slit skin smear (BI) and skin biopsy. Study spanned from January 2005 to December 2006.
Observations: Two MB cases (8%) evidenced features of clinical as well as bacteriological relapse, but none of the PB cases relapsed. The overall relapse rate was 6.9%. Relapsed patients reported after 1 and 5 years of release from treatment (RFT) and their newer clinical and bacteriological status was also lepromatous leprosy (LL) with BI 4+.
Conclusions: MDT is quite effective for treatment of leprosy, however, possibility of relapse is still there. Relapse rate showed wide variation in different studies.
Keywords
MDR, Relapse, BI, Leprosy.- Malignant Mixed Mullerian Tumour of Uterus
Authors
1 Department of Gynecology & Obstetrics, PGIMS, Rohtak, IN
2 Medical Gastroenterology, PGIMS, Rohtak, IN
3 Gynecology & Obstetrics, PGIMS, Rohtak, IN
4 Gynecology and Obstetrics, PGIMS, Rohtak, IR
Source
The Indian Practitioner, Vol 69, No 11 (2016), Pagination: 25-29Abstract
Background: Malignant mixed Mullerian tumors (MMMTs) are metaplastic carcinomas including both carcinomatous and sarcomatous elements. Case: A 65-year-old postmenopausal female presented to outpatient department with chief complaints of blood mixed vaginal discharge for the last 10 days. Speculum examination revealed a large, necrotic, foul smelling polyp of approximately 4 x 4 centimeters size seen coming out through the external os. Vaginal examination revealed that the cervix was dilated and taken up and the same polypoid mass was felt coming out through the os. Polypectomy along with endometrial biopsy was done and tissue was sent for histopathological examination which revealed features of malignant mixed mullerian tumor in the polyp and the endometrial biopsy showed necrotic tissue. Result: Patient underwent total abdominal hysterectomy along with bilateral salpingoopherectomy and pelvic lymphnode sampling. On cut section of the uterine corpus, a polypoid growth of size 3 x 2 centimeters was identified which on histopathology confirmed the diagnosis of a homologous uterine malignant mixed mullerian tumor involving more than half the thickness of myometrium. Conclusion: With a highly aggressive nature and limited therapeutic options, MMMTs represent one of the most lethal neoplasms of the female genitourinary tract.Keywords
Polyp, Abnormal Uterine Bleeding.References
- Benedet JL, Miller DM. Tumors of the fallopian tube: Clinical features, staging and management. In: Coppleson M, ed. Gynecologic Oncology, Vol. 2, 2nd ed. Edinburgh, Scotland: Churchill Livingstone, 1992:853.
- McCluggage WG. Uterine carcinosarcomas (malignant mixed Mullerian tumors) are metaplastic carcinomas. Int J Gynecol Cancer 2002; 12:687.
- Mira JL, Fenoglio-Preiser CM, Husseinzadeh N. Malignant mixed Mullerian tumor of the extra ovarian secondary Mullerian system: Report of two cases and review of the English literature. Arch Pathol Lab Med 1995; 119:1044.
- Wheeler JE. Diseases of the fallopian tube. In: Kurman RJ, ed. Blaustein’s Pathology of the Female Genital Tract, 3rd ed. New York, NY: Springer-Verlag, 1987:426.
- Shen DH, Khoo US, Xue WC, Ngan HY, Wang JL, Liu VW, et al. Primary peritoneal malignant mixed Mullerian tumors: A clinicopathologic, immunohistochemical and genetic study. Cancer 2001; 91:1052.
- Nimaroff M, Gal D, Susin M, et al. Extragenital malignant mixed mullerian tumor. Eur J Gynaecol 1993; 14:23.
- Lauchlan SC.Conceptual unity of the Mullerian tumor group. Cancer 1968; 22:601.
- Woodruff D, Solomon D, Sullivant H. Multifocal disease in the upper genital canal.Obstet Gynecol 1985;65:695.
- Sica V, Nola F, Contieri E, et al. Estradiol and progesterone receptors in malignant gastrointestinal tumors. Cancer Res 1984; 44:4670.
- Malhotra V, Nanda S, Chauhan M, Marwah N, Sen R. Heterologous Malignant Mixed Mullerian Tumor of the Uterus and Fallopian Tube: A Case Report. J Gynecol Surg 2012; 28(4): 296-98.
- Cass I, Resnik E, Chambers JT, et al. Combination chemotherapy with etoposide, cisplatin and doxorubicin in mixed Mullerian tumors of the adenexa. Gynaecol Oncol 1996; 61:309.
- Carlson JA, Jr, Ackerman BL, Wheeler JE. Malignant mixed Mullerian tumor of the fallopian tube. Cancer 1993; 71:187.
- Weber AM, Hewett WF, Gajewski WH, et al. Malignant mixed Mu ¨llerian tumors of the fallopian tube. Gynecol Oncol 1993; 50:239.